SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001479290-20-000034
Filing Date
2020-02-19
Accepted
2020-02-19 20:25:02
Documents
1
Period of Report
2020-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_158216186620685.html 4/A  
1 FORM 4/A wf-form4a_158216186620685.xml 4/A 2737
  Complete submission text file 0001479290-20-000034.txt   4094
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ZELTIQ AESTHETICS INC. 4698 WILLOW ROAD SUITE 100 PLEASANTON CA 94588
Business Address
Foley Mark J (Reporting) CIK: 0001529196 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36297 | Film No.: 20632146